Log In
BCIQ
Print this Print this
 

Oral BAL101553

  Manage Alerts
Collapse Summary General Information
Company Basilea Pharmaceutica Ltd.
DescriptionWater-soluble prodrug of BAL27862, an apoptosis-inducing small molecule targeting tubulin
Molecular Target Tubulin
Mechanism of ActionTubulin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced or recurrent solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today